HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahmoud Al Rifai Selected Research

Glucagon-Like Peptide-1 Receptor Agonists

1/2022Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahmoud Al Rifai Research Topics

Disease

33Cardiovascular Diseases (Cardiovascular Disease)
11/2023 - 08/2015
22Atherosclerosis
11/2023 - 04/2015
14Heart Failure
11/2023 - 11/2017
13Hypertension (High Blood Pressure)
10/2023 - 01/2017
7Myocardial Infarction
01/2023 - 11/2017
6Diabetes Mellitus
12/2022 - 12/2018
6Inflammation (Inflammations)
11/2021 - 03/2015
5Dyslipidemias (Dyslipidemia)
03/2024 - 01/2021
5Coronary Disease (Coronary Heart Disease)
11/2023 - 06/2015
5Obesity
09/2023 - 04/2015
5Hemorrhage
01/2023 - 01/2016
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2016
3Atrial Fibrillation
11/2023 - 01/2021
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2023 - 10/2020
3Chronic Renal Insufficiency
01/2022 - 10/2021
3Acute Coronary Syndrome
10/2021 - 11/2019
3COVID-19
03/2021 - 10/2020
2Weight Loss (Weight Reduction)
03/2024 - 11/2019
2Stroke (Strokes)
11/2023 - 12/2017
2Hypertriglyceridemia
01/2023 - 01/2021
2Cardiomyopathies (Cardiomyopathy)
01/2023 - 08/2017
2Genetic Risk Score
09/2022 - 01/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021 - 04/2015
2Infections
03/2021 - 10/2020
2Neoplasms (Cancer)
01/2020 - 01/2019
1Prediabetic State (Prediabetes)
02/2024
1Ischemic Stroke
11/2023
1Hypotension (Low Blood Pressure)
01/2023
1Ischemia
01/2023
1Takotsubo Cardiomyopathy
01/2023
1Pathologic Constriction (Stenosis)
11/2022
1Orthostatic Hypotension (Postural Hypotension)
11/2022
1Cardiac Arrhythmias (Arrythmia)
09/2022
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2022
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2022
1Fibrosis (Cirrhosis)
11/2021
1Premature Menopause
10/2021
1Human Influenza (Influenza)
03/2021
1Isolated Systolic Hypertension
01/2021

Drug/Important Bio-Agent (IBA)

24CalciumIBA
02/2024 - 04/2015
11Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2023 - 12/2018
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 01/2016
7Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2017
5Glucose (Dextrose)FDA LinkGeneric
02/2024 - 01/2016
5LipidsIBA
01/2022 - 01/2019
4Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2021 - 01/2020
4C-Reactive ProteinIBA
01/2017 - 03/2015
3Hemoglobins (Hemoglobin)IBA
02/2024 - 12/2018
3eicosapentaenoic acid ethyl esterIBA
01/2023 - 01/2020
3CholesterolIBA
11/2022 - 01/2019
3Proprotein Convertase 9IBA
01/2022 - 10/2021
3omega-Chloroacetophenone (Mace)IBA
01/2022 - 11/2017
3dapagliflozinIBA
10/2021 - 01/2019
3evinacumabIBA
01/2021 - 01/2020
3LDL CholesterolIBA
01/2020 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
11/2023 - 01/2017
2Triglycerides (Triacylglycerol)IBA
01/2023 - 01/2023
2pro-brain natriuretic peptide (1-76)IBA
01/2023 - 01/2021
2Growth Differentiation Factor 15IBA
01/2023 - 01/2021
2Brain Natriuretic Peptide (Natrecor)FDA Link
01/2023 - 01/2023
2Antihypertensive Agents (Antihypertensives)IBA
11/2022 - 10/2020
2Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 01/2022
2SodiumIBA
01/2022 - 01/2022
2evolocumabIBA
10/2021 - 11/2019
2empagliflozinIBA
10/2021 - 10/2020
2Troponin T (Troponin T1)IBA
01/2021 - 01/2017
2oxidized low density lipoproteinIBA
01/2020 - 01/2018
2alirocumabIBA
01/2020 - 11/2019
2Fibrinogen (Factor I)FDA Link
01/2017 - 03/2015
1Illicit Drugs (Recreational Drugs)IBA
03/2024
1CytokinesIBA
11/2023
1Interleukin-18 (Interleukin 18)IBA
11/2023
1Complement System Proteins (Complement)IBA
10/2023
1EnzymesIBA
01/2023
1EstersIBA
01/2023
1lipoprotein cholesterolIBA
01/2023
1Phenobarbital (Luminal)FDA Link
11/2022
1VaccinesIBA
09/2022
1Sodium-Glucose Transport ProteinsIBA
01/2022
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2022
1PCSK9 InhibitorsIBA
01/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022
1Glucagon-Like Peptide-1 ReceptorIBA
01/2022
1LectinsIBA
11/2021
1Galectin 3 (LGALS3)IBA
11/2021
1RivaroxabanIBA
10/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
03/2021
1Eicosapentaenoic AcidIBA
01/2021
1(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA
01/2021
1Atorvastatin (Lipitor)FDA Link
01/2021
1Clopidogrel (Plavix)FDA Link
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021

Therapy/Procedure

14Therapeutics
01/2023 - 01/2016
5Percutaneous Coronary Intervention
01/2023 - 01/2021
4Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2023 - 10/2021
3Secondary Prevention
01/2020 - 10/2018
2Drug Therapy (Chemotherapy)
01/2021 - 03/2016
1Obesity Management
09/2023
1Bariatric Surgery
09/2023
1Cardiac Rehabilitation
03/2022